GSE239844 crizotinib 8 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844_crizotinib_8_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844_crizotinib_8_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844_crizotinib_8_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844_crizotinib_8_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

PAX8 antisense RNA 1

Gene

TPTE pseudogene 1

Gene

SLC5A4 antisense RNA 1

Gene

HOXB cluster antisense RNA 1

Gene

zinc finger protein 300 pseudogene 1

Gene

long intergenic non-protein coding RNA 689

Gene

HOXC cluster antisense RNA 2

Gene

charged multivesicular body protein 1B2, pseudogene

Gene

long intergenic non-protein coding RNA 452

Gene

PRDM6 antisense RNA 1

  • Gene

    PAX8 antisense RNA 1


  • Gene

    TPTE pseudogene 1


  • Gene

    SLC5A4 antisense RNA 1


  • Gene

    HOXB cluster antisense RNA 1


  • Gene

    zinc finger protein 300 pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 689


  • Gene

    HOXC cluster antisense RNA 2


  • Gene

    charged multivesicular body protein 1B2, pseudogene


  • Gene

    long intergenic non-protein coding RNA 452


  • Gene

    PRDM6 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.